Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2019 | 01-2019 | 10-2018 | 07-2018 | 04-2018 | |
| Operating Expenses | 1,127 | 1,416 | 987 | 1,499 | 1,117 |
| Operating Income | -1,127 | -1,416 | -987 | -1,499 | -1,117 |
| Interest Expense | 3 | 8 | 10 | -164 | 178 |
| Other Income | -18 | 161 | 193 | -336 | -4 |
| Pre-tax Income | -1,148 | -1,262 | -804 | -1,671 | -1,298 |
| Net Income Continuous | -1,148 | -1,253 | -804 | -1,640 | -1,298 |
| Net Income | $-1,148 | $-1,253 | $-804 | $-1,640 | $-1,298 |
| EPS Basic Total Ops | -2.36 | -2.40 | -2.33 | -6.06 | -2.37 |
| EPS Basic Continuous Ops | -1.98 | -2.33 | -1.52 | -4.65 | -3.13 |
| EPS Diluted Total Ops | -2.36 | -2.40 | -2.33 | -6.06 | -2.37 |
| EPS Diluted Continuous Ops | -1.98 | -2.33 | -1.52 | -4.65 | -3.13 |
| EBITDA(a) | $-1,137 | $-1,411 | $-970 | $-1,486 | $-1,117 |